Denali Therapeutics Inc. (DNLI) shares outstanding

Shares outstanding · fiscal 2025
172.65M

Denali Therapeutics Inc. (DNLI) had 172.65M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 5.0% higher than the 164.47M of fiscal 2024. Figures as of 18 Nov 2026, 11:57 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
172.65M
Change on fiscal 2024
+5.0%
Growth, 5 years
+8.9% a year
Highest on record
172.65Mfiscal 2025
Lowest on record
92.62Mfiscal 2018
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Denali Therapeutics Inc. shares outstanding, in more detail

The market data feed counts 160.29M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 8.9% a year. Across the 8 fiscal years on record (2018–2025), the highest was 172.65M in fiscal 2025 and the lowest 92.62M in fiscal 2018.

History · 8 fiscal years

Shares outstanding by fiscal year

Denali Therapeutics Inc. shares outstanding, year by year

Denali Therapeutics Inc. (DNLI) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025172.65M 5.0% up
2024164.47M 19.7% up
2023137.37M 9.4% up
2022125.53M 3.3% up
2021121.52M 7.8% up
2020112.70M 17.9% up
201995.61M 3.2% up
201892.62M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on DNLI

Denali Therapeutics Inc., figure by figure

Denali Therapeutics Inc. (DNLI) overview: price, valuation and scorecard

Denali Therapeutics Inc. shares outstanding: questions and answers

How many shares does Denali Therapeutics Inc. have?

Denali Therapeutics Inc. (DNLI) had 172.65M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 5.0% higher than the 164.47M of fiscal 2024. The market data feed counts 160.29M shares outstanding today.

What is the growth rate of Denali Therapeutics Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 8.9% a year.

What are the highest and lowest diluted share count figures on record for Denali Therapeutics Inc.?

Across the 8 fiscal years on record (2018–2025), the highest was 172.65M in fiscal 2025 and the lowest 92.62M in fiscal 2018.

How is Denali Therapeutics Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Denali Therapeutics Inc. it is on record here for 8 fiscal years, 2018 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Denali Therapeutics Inc. (DNLI) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/DNLI/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.